{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:06:17Z","timestamp":1785179177348,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen Idec Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jns.2023.120552","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T15:03:39Z","timestamp":1674140619000},"page":"120552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"446","author":[{"given":"Anna","family":"Kabanovski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Zaslavsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120552_bb0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.msard.2017.11.017","article-title":"Longitudinal study of retinal nerve fiber layer thickness changes in a multiple sclerosis patients cohort: a long term 5 year follow-up","volume":"19","author":"Abalo-Lojo","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.jns.2023.120552_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001159","article-title":"Dynamics of retinal vessel loss after acute optic neuritis in patients with relapsing multiple sclerosis","volume":"9","author":"Aly","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.jns.2023.120552_bb0015","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","article-title":"Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study","volume":"263","author":"Balk","year":"2016","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120552_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jns.2023.120552_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.035","article-title":"Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis: a longitudinal MRI study","volume":"1325","author":"Bendfeldt","year":"2010","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.jns.2023.120552_bb0030","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-017-8531-y","article-title":"Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis","volume":"264","author":"Britze","year":"2017","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.120552_bb0035","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","article-title":"Optical coherence tomography in multiple sclerosis","volume":"32","author":"Britze","year":"2018","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.jns.2023.120552_bb0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1352458520935724","article-title":"Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis","volume":"27","author":"Bsteh","year":"2021","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.jns.2023.120552_bb0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1212\/WNL.0000000000003582","article-title":"Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study","volume":"88","author":"Button","year":"2017","journal-title":"Neurology."},{"issue":"11","key":"10.1016\/j.jns.2023.120552_bb0050","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/brain\/awy245","article-title":"Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study","volume":"141","author":"Caldito","year":"2018","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2023.120552_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WNO.0000000000000802","article-title":"Long-term stability of Neuroaxonal structure in Alemtuzumab-treated relapsing-remitting multiple sclerosis patients","volume":"40","author":"Chan","year":"2020","journal-title":"J. Neuroophthalmol."},{"issue":"Pt 9","key":"10.1016\/j.jns.2023.120552_bb0065","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","article-title":"Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis","volume":"124","author":"Evangelou","year":"2001","journal-title":"Brain."},{"key":"10.1016\/j.jns.2023.120552_bb0075","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/bjo.2010.199232","article-title":"Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients","volume":"95","author":"Garcia-Martin","year":"2011","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.jns.2023.120552_bb0085","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/brain\/awy245","article-title":"Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study","volume":"141","author":"Gonzalez Caldito","year":"2018","journal-title":"Brain."},{"issue":"4","key":"10.1016\/j.jns.2023.120552_bb0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10072-014-1982-3","article-title":"Acute optic neuritis: retinal ganglion cell loss precedes retinal nerve fiber thinning","volume":"36","author":"Huang-Link","year":"2015","journal-title":"Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2023.120552_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3988\/jcn.2015.11.3.241","article-title":"Benign multiple sclerosis is associated with reduced thinning of the retinal nerve Fiber and ganglion cell layers in non-optic-neuritis eyes","volume":"11","author":"Huang-Link","year":"2015","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jns.2023.120552_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.26.6_Part_2.26","article-title":"Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States","volume":"26","author":"Ikuta","year":"1976","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.120552_bb0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/ene.13770","article-title":"Retinal vascular density in multiple sclerosis: a 1-year follow-up","volume":"26","author":"Lanzillo","year":"2018","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2023.120552_bb0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(08)70200-X","article-title":"Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the Rebif vs Glatiramer acetate in relapsing MS disease [REGARD] study): a multicentre, randomised, parallel, open-label trial","volume":"7","author":"Mikol","year":"2008","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.jns.2023.120552_bb0115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1177\/1352458514523498","article-title":"Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis","volume":"20","author":"Narayanan","year":"2014","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.jns.2023.120552_bb0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.jns.2023.120552_bb0130","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1007\/s10072-020-04431-4","article-title":"Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study","volume":"41","author":"Pietroboni","year":"2020","journal-title":"Neurol. Sci."},{"issue":"24","key":"10.1016\/j.jns.2023.120552_bb0135","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1212\/WNL.0000000000004736","article-title":"No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS","volume":"89","author":"Pisa","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120552_bb0140","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jns.2023.120552_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41582-019-0170-8","article-title":"Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis","volume":"15","author":"Rotstein","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2023.120552_bb0150","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.jns.2023.120552_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/1352458511418630","article-title":"Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness","volume":"17","author":"Saidha","year":"2011","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.jns.2023.120552_bb0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaneurol.2013.573","article-title":"Retinal axonal and neuronal measures in multiple sclerosis reflect global CNS pathology","volume":"70","author":"Saidha","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2023.120552_bb0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in MS: a four year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120552_bb0170","first-page":"211","article-title":"Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis","volume":"3","author":"Toussaint","year":"1983","journal-title":"J. Clin. Neuroophthalmol."},{"key":"10.1016\/j.jns.2023.120552_bb0175","article-title":"The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis","volume":"10","author":"Tsivgoulis","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jns.2023.120552_bb0180","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1212\/WNL.0000000000006873","article-title":"Optical coherence tomography is highly sensitive in detecting prior optic neuritis","volume":"92","author":"Xu","year":"2019","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.jns.2023.120552_bb0185","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.ophtha.2014.06.047","article-title":"Relationship between ganglion cell layer thickness and estimated retinal ganglion cell counts in the glaucomatous macula","volume":"121","author":"Zhang","year":"2014","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jns.2023.120552_bb0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40263-018-0521-9","article-title":"The effect of glatiramer acetate on retinal nerve fiber layer thickness in patients with relapsing-remitting multiple sclerosis: a longitudinal optical coherence tomography study","volume":"32","author":"Zivadinov","year":"2018","journal-title":"CNS Drugs."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:51:35Z","timestamp":1762210295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S0022510X23000126"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120552","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120552"}}